Expert Consensus Document

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

The American Diabetes Association, the American Heart Association, and the American College of Cardiology Foundation make every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest. Peer reviewed by the American Diabetes Association, the American Heart Association, and the American College of Cardiology Foundation in November 2009 and revised January 2010; approved by all three organizations in March 2010.

The American College of Cardiology Foundation requests that this document be cited as follows: Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, and Kirkman MS. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation. J Am Coll Cardiol 2010;55:2878–86.

This article has been copublished in Diabetes Careand Circulation.

Copies: This document is available on the World Wide Web site of the American College of Cardiology (www.acc.org). For copies of this document, please contact Elsevier Inc. Reprint Department, fax (212) 633-3820, e-mail [email protected].

Permissions: Modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Please contact Elsevier's permission department at [email protected].

Writing Group Chair